Predict your next investment

Corporation
id-edd.com

See what CB Insights has to offer

Partners & Customers

5

About Innovative Discovery

Innovative Discovery provides data management and risk mitigation services to law firms and corporations.

Innovative Discovery Headquarter Location

700 North Moore Street Suite 1500

Arlington, Virginia, 22209,

United States

703-875-8003

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Innovative Discovery News

Prestige BioPharma Commences Construction of Innovative Discovery Center (IDC) in Busan, Korea

Dec 19, 2021

Download PBP's Innovative Discovery Center (IDC) in Busan, Korea (Photo: Business Wire) December 19, 2021 05:00 PM Eastern Standard Time SINGAPORE--( BUSINESS WIRE )--Prestige BioPharma Limited (PBP, 950210: KRX), a Singapore-based biopharmaceutical with operations in USA and South Korea, commences construction of Innovative Discovery Center (IDC) in Busan, South Korea. The construction of IDC is scheduled for completion by February 2023. PBP holds a groundbreaking ceremony on December 21, 2021 with Korean government officials and guests including Deputy Mayor of Busan City Mr. Yoon-il Kim, Director General for Investment Policy of the Ministry of Trade, Industry and Energy Mr. Jong-young Jung and Head of Development Administration Division in Busan-Jinhae Free Economic Zone Authority (BJFEZ) Mr. Seokho Cha. PBP is on target to build the global-scale R&D centre with a total area of approximately 34,000 square meters and facilities sufficient for 800 researchers. Earlier in May this year, PBP and Busan City Government had signed an MOU for the establishment of IDC in which the company’s plan to invest over US$200 million by 2030 was announced. IDC will be focusing on diverse first-in-class antibody biologics discovery starting from 8 bispecific antibody projects based on PBP’s proprietary oncology therapeutic targets, PAUF and CTHRC1. Next generation vaccines using mRNA technologies and bioinformatics will be developed in IDC for current and potential future pandemics. IDC also will be hiring more than 250 of PhD and highly qualified R&D personnel over the next five years and fifty percent of its R&D resources will be sourced from local universities and community. As the first global scale R&D center in Busan, IDC is expected to lead the growth of Busan’s bioindustry and to lay a foundation to make the region into a viable bio-cluster that supports the local economy and drives mutual growth in academia and industry. IDC is planning to implement an open innovation platform that provides the local biomedical society a ‘one stop’ R&D solution for full cycle of new drug development targeting global markets. PBP’s CEO, Dr Lisa S. Park commented: “IDC will be leading PBP Group’s innovative drug discovery R&D in connection with our research centers in Singapore and US and creating a global open innovation hub for industry-academic collaboration” and “we envision IDC where Prestige Biopharma’s innovation realizes and the start of a new world-class bio-cluster here in Busan”. Hyeong-joon Park, Mayor of Busan City, commented: “We are very excited to have a global scale bio-R&D center in Busan and work with a global leading bio-pharmaceutical company, Prestige Biopharma. Busan City will fully support PBP’s IDC so this novel partnership can lead a local bio-industry’s growth and contribute to local economic development and high-quality job creation”. Contacts

Innovative Discovery Acquisitions

1 Acquisition

Innovative Discovery acquired 1 company. Their latest acquisition was Integro on September 04, 2020.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

9/4/2020

$99M

Acquired

2

Date

9/4/2020

Investment Stage

Companies

Valuation

$99M

Total Funding

Note

Acquired

Sources

2

Innovative Discovery Partners & Customers

5 Partners and customers

Innovative Discovery has 5 strategic partners and customers. Innovative Discovery recently partnered with OneTrust on August 8, 2021.

Date

Type

Business Partner

Country

News Snippet

Sources

8/2/2021

Vendor

United States

Innovative Discovery Becomes a OneTrust Certified Partner.

The partnership allows Innovative Discovery to implement OneTrust , GRC , and DataDiscovery modules .

1

8/27/2020

Licensor

United States

Subscribe to see more

Subscribe to see more

10

6/8/2020

Vendor

United States

Subscribe to see more

Subscribe to see more

10

10/16/2019

Partner

United States

Subscribe to see more

Subscribe to see more

10

9/5/2019

Licensor

United States

Subscribe to see more

Subscribe to see more

10

Date

8/2/2021

8/27/2020

6/8/2020

10/16/2019

9/5/2019

Type

Vendor

Licensor

Vendor

Partner

Licensor

Business Partner

Country

United States

United States

United States

United States

United States

News Snippet

Innovative Discovery Becomes a OneTrust Certified Partner.

The partnership allows Innovative Discovery to implement OneTrust , GRC , and DataDiscovery modules .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.